Miraculins Closes $400,000 Private Placement

Life Science Investing News

Miraculins (TSXV:MOM) has closed its recently announced private placement offering for gross proceeds of $400,000. Proceeds of the offering will be used for general corporate purposes.

Miraculins (TSXV:MOM) has closed its recently announced private placement offering for gross proceeds of $400,000. Proceeds of the offering will be used for general corporate purposes.

As quoted in the press release:

Each whole Warrant entitles the holder to purchase one Share at a price of $0.15 per Share for a period of two years from the date the Warrant is issued. The Shares and Warrants will be restricted from transfer for a period of four months and a day from the date hereof in accordance with applicable securities laws. The net proceeds of the Offering shall be used for general corporate purposes.

Certain persons assisted the Company by introducing potential subscribers for the Offering and were paid a finder’s fee of 8% of the total subscription proceeds received from subscribers introduced to the Company by each particular person. Additionally, these persons were issued compensation warrants (“Compensation Warrants”) equal to 8% of the total number of Units subscribed for by subscribers introduced to the Company by each particular person. Each Compensation Warrant entitles the holder thereof to purchase one Share at a price of $0.15 per Share for a period of two years from the date of issue. The Compensation Warrants will be restricted from transfer for a period of four months and a day from the date hereof in accordance with applicable securities laws.

Click here to read the Miraculins (TSXV:MOM) press release
Click here to see the Miraculins (TSXV:MOM) profile.

The Conversation (0)
×